Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.52 -0.09 (-3.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zentalis Pharmaceuticals (ZNTL) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Zentalis Pharmaceuticals' Return on Capital Employed [ROCE] was -78.02% in Q2 2026, down 22.39 percentage points from -55.64% a year earlier and down 16.51 percentage points from the prior quarter.

Analysis

Zentalis Pharmaceuticals (ZNTL) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Zentalis Pharmaceuticals came in at -47.30%, down 3.67 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +12.72 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -43.62% in FY2024 (+19.28 pp), -62.90% in FY2023 (-11.28 pp), -51.63% in FY2022 (+7.52 pp) and -59.15% in FY2021 (+0.87 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2020.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has declined for six straight quarters, with an average year-over-year change of -4.80 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2022 (a gain of 19.92 percentage points); the worst was Q3 2021 (a drop of 34.15 percentage points).
  • Per Business Quant data, ZNTL's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -61.51% (Q1 2026), -56.27% (Q4 2025) and -54.67% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Zentalis Pharmaceuticals 180.60 Mn 180.60 Mn - -78.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -78.02%
Mar 31, 2026 -61.51%
Dec 31, 2025 -56.27%
Sep 30, 2025 -54.67%
Jun 30, 2025 -55.64%
Mar 31, 2025 -59.27%
Dec 31, 2024 -49.31%
Sep 30, 2024 -50.27%
Jun 30, 2024 -48.17%
Mar 31, 2024 -51.89%
Dec 31, 2023 -59.98%
Sep 30, 2023 -52.02%
Jun 30, 2023 -54.57%
Mar 31, 2023 -51.17%
Dec 31, 2022 -47.59%
Sep 30, 2022 -45.25%
Jun 30, 2022 -53.04%
Mar 31, 2022 -57.96%
Dec 31, 2021 -54.02%
Sep 30, 2021 -65.16%
API Access

Zentalis Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ZNTL&period=max&api_key=YOUR_API_KEY